Parkinson's disease: are PINK1 activators inching closer to the clinic?

Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513 2023. Parkinson's disease: are PINK1 activators inching closer to the clinic? ACS Medicinal Chemistry Letters 14 (7) , pp. 870-874. 10.1021/acsmedchemlett.3c00070

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview

Abstract

The activation of PINK1 by small molecules has emerged as a promising strategy in treating Parkinson’s disease (PD). Recent progress in this area has raised excitement around PINK1 activators as PD treatments, and herein we offer insight into these developments and their potential to deliver much needed novel PD treatments.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy
Publisher:	American Chemical Society
ISSN:	1948-5875
Date of First Compliant Deposit:	3 July 2023
Date of Acceptance:	31 May 2023
Last Modified:	06 Sep 2023 17:16
URI:	https://orca.cardiff.ac.uk/id/eprint/160783

Actions (repository staff only)

Edit Item